| Intervention group | Control group |
---|---|---|
n = 30 | n = 38 | |
Age, mean (SD) years | 13.4 (3.1) | 13.1 (3.1) |
Gender, male n (%) male | 16 (53%) | 21 (55%) |
Height, mean (SD) cm | 158.9 (16.5) | 154.5 (17.2) |
Weight, mean (SD) kg | 51.6(16.0) | 49.2 (16.9) |
Cancer type, n (%) | ||
 ALL | 8 (27%) | 12 (32%) |
 AML, HL, non-HL, CML, Burkitt | 12 (40%) | 13 (34%) |
 CNS/brain tumor | 1 (3%) | 6 (16%) |
 Solid tumor | 9 (30%) | 7 (18%) |
During treatment, n (%) | 9 (30%) | 12 (32%) |
Lower body amputations | 2 (3%) | 2 (3%) |
Upper body amputations | 2 (3%) | 1 (1%) |